Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kristy L. Richards
A Phase II Trial of Bendamustine in Combination With Rituximab in Older Patients With Previously Untreated Diffuse Large B-Cell Lymphoma
British Journal of Haematology
Hematology
Obstacles to Affordable Cancer Treatments
North Carolina Medical Journal
Medicine
Related publications
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
Annals of Hematology
Medicine
Hematology
Combination of Ibrutinib With Rituximab (Ir) Is Highly Effective in Previously Untreated Elderly (>65 Years) Patients (Pts) With Mantle Cell Lymphoma (Mcl) - Phase Ii Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase Ii Study of Lenalidomide and Rituximab (R²) Combination in Patients With High-Risk Refractory/Relapsed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Pembrolizumab With Rchop in Previously Untreated Diffuse Large B-Cell and Grade 3b Follicular Lymphoma: Final Results of a Phase I Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Antitumor Activity of the Combination of Bendamustine With Vorinostat in Diffuse Large B-Cell Lymphoma Cells
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
R-Chop With or Without Bevacizumab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma: Final MAIN Study Outcomes
Haematologica
Hematology
Accept: A Phase Ib/Ii Combination of Acalabrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisolone (R-Chop) for Patients With Diffuse Large B-Cell Lymphoma (Dlbcl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Safety and Clinical Activity of Temsirolimus in Combination With Rituximab and Dhap in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma-Report of the Prospective, Multicenter Phase Ii Storm Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
